SkinHealth Systems Inc. Increase (Decrease) in Accounts Payable
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-03-12
- SkinHealth Systems Inc. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$7.32M, a 139.42% decline year-over-year.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was -$616.00K.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $10.34M.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$2.66M, a 186.86% decline year-over-year.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for fiscal 2023 was $15.78M.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for fiscal 2022 was -$262.00K, a 102.49% decline from fiscal 2021.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for fiscal 2021 was $10.52M, a 115.24% increase from fiscal 2020.
- SkinHealth Systems Inc. increase (decrease) in accounts payable for fiscal 2020 was $4.89M, a 13.41% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $15.78M 10-K · filed 2024-03-12 | ||||
| 2022-12-31 | -$7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$7.94M derived: sum of 2 quarters · filed 2024-03-12 | $2.40M derived: sum of 3 quarters · filed 2024-03-12 | -$262.00K 10-K · filed 2024-03-12 | $1.61M 10-K · filed 2023-03-01 |
| 2022-09-30 | -$616.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.72M derived: sum of 2 quarters · filed 2022-11-09 | $7.06M 10-Q · filed 2022-11-09 | $25.63M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-06-30 | $10.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.67M 10-Q · filed 2022-08-09 | $26.25M derived: sum of 3 quarters · filed 2024-03-12 | $20.57M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-03-31 | -$2.66M 10-Q · filed 2022-05-10 | $15.91M derived: sum of 2 quarters · filed 2024-03-12 | $10.23M derived: sum of 3 quarters · filed 2024-03-12 | $4.79M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2021-12-31 | $18.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $12.89M derived: sum of 2 quarters · filed 2024-03-12 | $7.46M derived: sum of 3 quarters · filed 2024-03-12 | $10.52M 10-K · filed 2024-03-12 | |
| 2021-09-30 | -$5.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$11.12M derived: sum of 2 quarters · filed 2022-11-09 | -$8.05M 10-Q · filed 2022-11-09 | -$1.76M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$5.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.37M 10-Q · filed 2022-08-09 | $3.92M derived: sum of 3 quarters · filed 2023-03-01 | $329.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $3.07M 10-Q · filed 2022-05-10 | $9.35M derived: sum of 2 quarters · filed 2023-03-01 | $5.76M derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.70M derived: sum of 2 quarters · filed 2023-03-01 | $4.89M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.40M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $2.19M 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | $4.31M 10-K · filed 2022-03-01 |